Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 6/20 | 0.47 |
| ▸ | EPAS1 | Q99814 | 6/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | LOX | P28300 | 1/20 | 0.32 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.32 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2588505 | 1.00 | HIF1A (0.47) | HIF1AEPAS1TSHRALDH1A1TDP1 | |
| SCHEMBL2588504 | 1.00 | HIF1A (0.47) | HIF1AEPAS1TSHRALDH1A1TDP1 | |
| SCHEMBL29066917 | 1.00 | HIF1A (0.47) | HIF1AEPAS1TSHRALDH1A1TDP1 | |
| SCHEMBL21441801 | 0.88 | TSHR (0.44) | HIF1AEPAS1TSHRALDH1A1TDP1 | |
| SCHEMBL23119378 | 0.88 | FAAH (0.52) | HIF1AEPAS1TSHRALDH1A1TDP1 | |
| SCHEMBL25254569 | 0.88 | TSHR (0.56) | TSHRTDP1MAPTFAAHTRPV1 | |
| SCHEMBL21646324 | 0.88 | TSHR (0.44) | HIF1AEPAS1TSHRALDH1A1TDP1 | |
| SCHEMBL21328544 | 0.88 | EPAS1 (0.41) | HIF1AEPAS1TSHRALDH1A1TDP1 | |
| SCHEMBL22296738 | 0.88 | TSHR (0.56) | TSHRTDP1MAPTFAAHTRPV1 | |
| SCHEMBL22296755 | 0.88 | TSHR (0.56) | TSHRTDP1MAPTFAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2729456-B1 | PREPARATION OF NITRILE COMPOUNDS | DSM IP ASSETS BV (NL) | 2017-06-28 | — | — | EP | disclosed |
| US-9035078-B2 | Preparation of nitrile compounds | DSM IP ASSETS B.V. (NL) | 2015-05-19 | — | — | US | disclosed |
| US-20140213804-A1 | PREPARATION OF NITRILE COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2014-07-31 | — | — | US | disclosed |
| EP-2729456-A1 | PREPARATION OF NITRILE COMPOUNDS | DSM IP Assets B.V. (NL) | 2014-05-14 | — | — | EP | disclosed |
| WO-2013007634-A1 | PREPARATION OF NITRILE COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2013-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140213804-A1 | PREPARATION OF NITRILE COMPOUNDS | NOX1, NOXO1, NOS1 | HIF1A 566/4885EPAS1 4470/4885TSHR 4202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.